Huynh, Tri
El Hayek, Eliane
Ali, Abdulmehdi
Hernandez, Tessa
Zenon, Jania
Van Dunk, Connie
Mann, Vincent
Erdei, Esther
Zelikoff, Judith https://orcid.org/0000-0002-1510-2080
Article History
Received: 20 May 2026
Accepted: 7 July 2026
First Online: 22 July 2026
Declarations
Ethics approval: The protocol was approved by the NYU Langone Health Institutional Review Board (Study Number: i22-00248; Clinical trial number: NCT06315140, registered on March 5th, 2024), in accordance with the U.S. Common Rule (45 CFR 46), Good Clinical Practices (GCP), and applicable laws and regulations.
Consent to participate: Informed consent was obtained from all individual survey participants included in the study.
Consent for publication: Survey data were fully anonymized such that no individual can be identified, and no identifiable information is presented, so separate consent to publish was not required.
Competing interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.